Literature DB >> 7587941

Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.

L Y Lin1, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano, A K Cho.   

Abstract

The 4-hydroxylation of S(+)- and R(-)-methamphetamine by rat liver microsomes was examined in Sprague-Dawley and Dark Agouti strains to determine the role of cytochrome P4502D (CYP2D) subfamily isozymes in catalyzing the reaction. In the study, anti-P450-BTL IgG, bufuralol, and quinine, a substrate and inhibitors of CYP2D isozymes, respectively, were found to block approximately 90% of the reaction as catalyzed by microsomes from Sprague-Dawley rats. Reconstituted systems of CYP2D isozymes purified from rat liver microsomes also mediated the reaction. These observations and the minimal activity found in microsomes from Dark Agouti rats support the notion that methamphetamine, like other phenylisopropylamine compounds, is oxidized on the 4-position of the aromatic ring by CYP2D isozymes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7587941

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

1.  Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats.

Authors:  M Dostalek; E Hadasova; M Hanesova; J Pistovcakova; A Sulcova; J Jurica; J Tomandl; I Linhart
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

2.  Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy.

Authors:  Aaron M Kipp; Andrew J Desruisseau; Han-Zhu Qian
Journal:  J Subst Abuse Treat       Date:  2011-02-24

3.  Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity.

Authors:  X Deng; B Ladenheim; L I Tsao; J L Cadet
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

4.  An improved HPLC method for analysis of methamphetamine and its metabolites in plasma.

Authors:  N Y Li; Y Li; E M Sellers
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

Review 5.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

6.  Radiation Effects on Methamphetamine Pharmacokinetics and Pharmacodynamics in Rats.

Authors:  Mitchell R McGill; David L Findley; Anna Mazur; Eric U Yee; Felicia D Allard; Allison Powers; Lori Coward; Eric R Blough; Greg Gorman; Michael D Hambuchen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-02-08       Impact factor: 2.441

7.  The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization.

Authors:  Marlaina R Stocco; Ahmed A El-Sherbeni; Bin Zhao; Maria Novalen; Rachel F Tyndale
Journal:  Psychopharmacology (Berl)       Date:  2021-03-01       Impact factor: 4.530

8.  Acetaldehyde and parkinsonism: role of CYP450 2E1.

Authors:  Francesca Vaglini; Cristina Viaggi; Valentina Piro; Carla Pardini; Claudio Gerace; Marco Scarselli; Giovanni Umberto Corsini
Journal:  Front Behav Neurosci       Date:  2013-06-21       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.